scholarly journals Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury

2014 ◽  
Vol 35 (2) ◽  
pp. 335-343 ◽  
Author(s):  
Rita Garcia-Martinez ◽  
Lorette Noiret ◽  
Sambit Sen ◽  
Rajeshwar Mookerjee ◽  
Rajiv Jalan
2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Byeong Woo KIm ◽  
Sun hee Kim ◽  
Ki beom Bae

Abstract Background and Aims Although the mechanism of contrast-induced acute kidney injury (CI-AKI) is not fully known, the imbalance of vasoconstrictive and vasodilative mediators plays a major role. Prostaglandin E2 (PGE2) is one of the vasodilators involved in this process. Inhibition of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) causes elevation of PGE2 level in tissue by delaying the rapid degradation of PGE2 by the enzyme. We tested the hypothesis that the 15-PGE2 inhibitor would protect against CI-AKI in a mouse model and attempted to elucidate the mechanism involved. Method 10-week aged male C57/BL6 Mice were injected with 10gI/kg of iodixanol by tail vein. Renal blood flow measurement, right nephrectomy, and blood sampling were taken at 48 hours after iodixanol injection. The 15-PGDH inhibitor was injected before and after iodixanol administration. Plasma creatinine, NGAL, KIM-1 were measured as biomarkers for renal function. Histological evaluation was analyzed by the necrosis scoring system and TUNEL assay. Arteriolar area of outer medulla was analyzed by α-smooth muscle actin stain. Renal blood flow was measured by the non-invasive laser doppler. Results Plasma creatinine (1.94±0.75 vs 1.11±0.44 mg/dL, p=0.005), NGAL (299.7±115.87 vs 140.4±76.56 ng/mL, p=0.004), and KIM-1 (2.09±2.34 vs 0.43±0.89 ng/mL, p=0.024) levels were significantly lower when the 15-PGDH inhibitor was injected before and after iodixanol administration than the vehicle group. But no significant renal protective effect was shown when the 15-PGDH inhibitor was injected before or after iodixanol administration. The 15-PGDH inhibitor administration before and after iodixanol injection showed a significantly wider renal arteriolar area (683.63±248.46 vs 1132.97±357.46 μm2, p=0.039) and larger renal blood flow (360.0±49.72 vs 635.1±27.20, p=0.011) than vehicle administration. Conclusion The 15-PGDH inhibitor has a renal protective effect against CI-AKI in mice by increasing renal blood flow when injected intravenously before and after iodine contrast media administration.


2016 ◽  
Vol 90 (1) ◽  
pp. 22-24 ◽  
Author(s):  
Patrick M. Honore ◽  
Rita Jacobs ◽  
Elisabeth De Waele ◽  
Marc Diltoer ◽  
Herbert D. Spapen

2007 ◽  
Vol 33 (9) ◽  
pp. 1498-1500 ◽  
Author(s):  
Martin Matejovic ◽  
Peter Radermacher ◽  
Michael Joannidis

2010 ◽  
Vol 56 (4) ◽  
pp. 785-787 ◽  
Author(s):  
Filippo Mangione ◽  
Valeria Calcaterra ◽  
Ciro Esposito ◽  
Antonio Dal Canton

2012 ◽  
Vol 40 (6) ◽  
pp. 1972-1973
Author(s):  
Jean-Sebastien Rachoin

Author(s):  
Douglas Stewart ◽  
Gaurav Shah ◽  
Jeremiah R. Brown ◽  
Peter A. McCullough

Contrast-induced acute kidney injury (CI-AKI) occurs because all forms of intravascular contrast contain iodine and their biochemical structures induce immediate changes in systemic and renal vasoreactivity. In the kidneys, contrast induces a transient decrease in renal blood flow. This is more pronounced in patients with chronic kidney disease and diabetes mellitus. The reduction in blood flow allows slowed transit of contrast and reabsorption by the proximal tubular cells where contrast is directly toxic resulting in tubular cell dysfunction and death. When there is considerable damage, a transient rise in serum creatinine and reduction in urine output will be observed in the hours to days after contrast exposure. Principles to reduce CI-AKI include limiting the amount of contrast used, intravascular volume expansion to maximize renal blood flow and speed transit of contrast, and possibly agents to reduce the oxidative damage caused by the contrast agents themselves.


2007 ◽  
Vol 33 (9) ◽  
pp. 1614-1618 ◽  
Author(s):  
Christoph Langenberg ◽  
Li Wan ◽  
Moritoki Egi ◽  
Clive N. May ◽  
Rinaldo Bellomo

Sign in / Sign up

Export Citation Format

Share Document